Skip to main content

Mustang Energy Corp. Completes First Milestone of Option Agreement with Skyharbour Resources Ltd.

VANCOUVER, British Columbia, Dec. 06, 2024 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE:MEC, OTC:MECPF, FRA:92T) (“Mustang” or the “Company”) is excited to announce that it has completed the first milestone (the “First Milestone”) of the previously announced option agreement (the “Agreement”) with Skyharbour Resources Ltd. (TSX-V: SYH) (“Skyharbour”) dated November 12, 2024. Pursuant to the Agreement, Skyharbour agreed to grant the Company an option to acquire an undivided 75% interest (the “Option”) in Skyharbour’s 914W Uranium Project (the “914W Project”), located in the Athabasca Basin of Northern Saskatchewan. For more information regarding the Agreement, please refer to the Company’s news release dated November 13, 2024. The Company completed the First Milestone on November 27, 2024 (the “Closing Date”) by making a cash payment...

Continue reading

Voxtur Announces Amendments to Financial Statements and MD&A for Q3 Ended September 30, 2024

TORONTO and TAMPA, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced that, subsequent to the Company filing on November 28, 2024, certain disclosures were identified that require amendments to its Unaudited Condensed Interim Consolidated Financial Statements (“Financial Statements”) and the related Management’s Discussion and Analysis (“MD&A”) for the three and nine months ended September 30, 2024. Accordingly, the Company confirms that amended Financial Statements and the related MD&A have been filed on SEDAR+. The nature of the amendments include:(i)   Removal of the last sentence of the paragraph below,...

Continue reading

Brazilian Court Confirms Tenaris’s Obligation to Pay Indemnification in connection with its 2012 Acquisition of a Participation in Usiminas; the Decision is subject to Further Appeals

LUXEMBOURG, Dec. 06, 2024 (GLOBE NEWSWIRE) — Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced that the Brazilian Superior Court of Justice (SCJ) published today its unanimous decision to reject a motion of clarification filed by Tenaris’s subsidiary Confab, together with Ternium’s subsidiaries Ternium Investments and Ternium Argentina (all of which compose the T/T Group under the Usiminas shareholders agreement), that had sought to revert the June 18, 2024 SCJ decision ordering the T/T Group to pay Companhia Siderúrgica Nacional, or CSN, an indemnification in connection with their 2012 acquisition of a participation in Usiminas. Notwithstanding the foregoing, the SCJ unanimously resolved to modify the applicable monetary adjustment mechanism and to cap the applicable attorney’s fees, thereby lowering the aggregate...

Continue reading

Tandy Leather Factory Announces Agreement to Sell Headquarters Facilities

FORT WORTH, Texas, Dec. 06, 2024 (GLOBE NEWSWIRE) — Tandy Leather Factory, Inc. (the “Company”, Nasdaq: TLF) today announced that it had signed a Purchase and Sale Agreement to sell its corporate headquarters facilities, including its primary distribution center and flagship retail store, to Colonna Brothers, Inc. The sale price for the facilities, before taxes and expenses, will be $26.5 million, and the transaction is expected to close in January 2025. Upon the closing, the Company intends to enter into lease agreements to remain in its current spaces until approximately September 2025, while it identifies and prepares to move to new facilities in the Fort Worth, Texas area. Jeff Gramm, the Company’s Chairman, said, “As we announced last December, we have been marketing our headquarters property with hopes of unlocking value...

Continue reading

Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global industry leader in AI for transportation, today announced that, in connection with Antonio (“Tony”) Rodriquez’s recent appointment as Executive Vice President, Chief Financial Officer effective November 29, 2024, the Company granted Mr. Rodriquez 313,283 time-based restricted stock units and 313,283 performance-based restricted stock units. The time-based restricted stock units will vest in three equal installments on each of October 1, 2025, October 1, 2026, and October 1, 2027, in each case subject to Mr. Rodriquez’s continued service with the Company through the applicable vesting date. The performance-based restricted stock units will be earned based on the achievement of the Company’s performance metrics for each of fiscal...

Continue reading

Osisko Metals Acquires Additional Claims Near Gaspé Copper

MONTREAL, Dec. 06, 2024 (GLOBE NEWSWIRE) — Osisko Metals Incorporated (the “Company or “Osisko Metals“) (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce the acquisition of a group of 199 claims adjacent to its Gaspé Copper Project (the “Claims”). Pursuant to a sales agreement dated October 8, 2024 with the two private holders of the interest in the Claims, Osisko Metals acquired a 100% interest in the Claims in exchange for the issuance of 5,000,000 common shares of its capital stock and the grant of a 2% net smelter return royalty, half of which is redeemable for an amount of $2,000,000. The common shares issued in connection with the acquisition are subject to various restriction periods to a statutory hold period expiring four months and one day from the date of issue pursuant to applicable...

Continue reading

BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity

Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients enrolled to date and share updated plans for azelaprag in Q1 2025 In parallel to evaluating azelaprag, Company will continue to advance earlier platform-derived programs, including IND submission for CNS penetrant NLRP3 inhibitor anticipated in the second half of 2025 RICHMOND, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) — BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company has made the decision to discontinue the ongoing STRIDES Phase 2 study of its investigational drug candidate azelaprag...

Continue reading

IREN closes $440 million convertible notes offering

SYDNEY, Dec. 06, 2024 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (ACN 629 842 799) (“IREN”) today announced the closing of its offering of $440 million aggregate principal amount of 3.25% convertible senior notes due 2030 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Key details of the transactionOversubscribed and upsized from $300 million to $400 million, plus $40 million greenshoe Net proceeds of approximately $425.4 million 3.25% coupon, 30% conversion premium Capped call transactions entered into in connection with the notes are generally expected to provide a hedge upon conversions up to an initial cap price of $25.86 per share, which represents a 100% premium (as compared...

Continue reading

Insight Acquisition Corp Stockholders Approve Extension of Business Combination Period Through March 7, 2025

NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) — Insight Acquisition Corp. (NASDAQ: INAQ) announced today that its stockholders have approved an extension of the time period by which the Company has to consummate an initial business combination (the “Business Combination Period”) from December 7, 2024, to March 7, 2025 (the “Extended Termination Date”). The extension was made through the adoption of the Fourth Extension Amendment to the Company’s amended and restated certificate of incorporation (the “Charter”), which was filed today with the Delaware Secretary of State. Adoption of the Fourth Extension Amendment required approval by the affirmative vote of at least 65% of the Company’s outstanding shares of common stock. The proposal was approved by the Company’s stockholders holding 4,950,037 shares, representing approximately...

Continue reading

VivoPower to host Annual General Meeting on December 30, 2024 in London

London, Dec. 06, 2024 (GLOBE NEWSWIRE) — VivoPower International PLC (NASDAQ: VVPR) (the “Company” or “VivoPower”) is pleased to announce that it will hold its Annual General Meeting (“AGM”) at its offices in London on Monday, December 30, 2024, at 1:00 p.m. London time. The resolutions to be passed include:Laying of annual accounts and reports Directors’ remuneration report Re-appointment of auditors Remuneration of auditors Extension of the term of William Langdon appointment as director of the Company Approval for Mergers or DivestmentsThe formal notice of the AGM with accompanying proxy forms and dial in details will be mailed to shareholders in accordance with the statutory period prior to the AGM. About VivoPower  Established in 2014 and listed on Nasdaq since 2016, VivoPower is an award-winning global sustainable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.